Le dépistage du cancer du poumon

Abstract

Several randomized trials have demonstrated that a low-dose thoracic CT scan screening strategy without contrast injection reduces both lung cancer mortality and overall mortality in a high-risk population. In France and Europe, several scientific societies have advocated for this screening to be performed in eligible individuals. In France, the eligibility criteria are: age between 50 and 75 years, a smoking history of more than 20 pack-years, either current smokers or those who have quit within the last 15 years. The IMPULSION national pilot study will begin in 2025 in 5 regions and in the whole territory in 2026.